Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 381400 of 20,252 grants

Active OTHER RESEARCH-RELATED
Integrative Deep Learning Models for Multimodal Markers of Cancer Treatment Outcomes
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2024 – 2026

PROJECT SUMMARY The most pressing challenge in oncology is the need for accurate biomarker-driven prognostic/predictive risk- stratification to identify patients who are unlikely t...

$398.7K
USD
Active OTHER RESEARCH-RELATED
Discovery of Novel Therapeutic Strategies for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2026

Project Summary The central hypothesis of my F99-phase proposal is that the lack of T-cell infiltration into human tumors may be caused by the presence of tumor-derived T-cell excl...

$504.7K
USD
Completed NON-SBIR/STTR RPGS
IMAT-ITCR Collaboration: Multiplexed Spatial Data Calibration and analysis using micro-capsules
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2024 – 2025

Project summary A major goal of cancer research is to define the composition of the tumor micro-environment (TME) across individuals. Once measured, differences in TME composition...

$847.2K
USD
Completed NON-SBIR/STTR RPGS
IMAT-ITCR Collaboration: Engineering model-based systems to monitor and steer subclonal dynamics
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2025

PROJECT SUMMARY Ongoing cancer genomic studies have documented numerous mutations across all tumor types. Most cancer mutations have not been functionally characterized, as conduct...

$757.9K
USD
Completed RESEARCH CENTERS
Comprehensive Cancer Center Support Grant
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2025

Cervical cancer elimination as a public health problem has become a reality if we focus on the uptake of three evidence-based tools: HPV vaccination, cervical cancer screening, and...

$2M
USD
Completed RESEARCH CENTERS
Mayo CCCG (Supp) - Impact of Multi-Channel Communication Campaigns on Cancer Prevention, Control and Survivorship (CaPCaS) in Black, Hispanic, Rural, and Sexual and Gender Minority Populations
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2025

ABSTRACT This application is being submitted by the Mayo Clinic Comprehensive Cancer Center (MCCCC) to extend the period of support for the P30 Administrative Supplement for Multi-...

$2M
USD
Completed RESEARCH CENTERS
Communication in American Indians thru Strategies for Equity 4 Cancer (CASE4Cancer)
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2024 – 2025

PROJECT SUMMARY: Cancer continues to be the top cause of death for American Indians (AIs) in North Carolina. With higher rates of colorectal cancer (CRC) late stage diagnosis and m...

$2M
USD
Completed NON-SBIR/STTR RPGS
TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer
NATIONAL CANCER INSTITUTE University of Toledo Health Sci Campus United States 2024 – 2025

ABSTRACT Breast cancer (BC) is a complex and heterogeneous neoplastic disease with a high incidence and mortality. BC can be divided into clinical, histopathologic, and molecular s...

$492K
USD
Completed RESEARCH CENTERS
P30 Administrative Supplement for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2024 – 2025

PROJECT ABSTRACT Childhood cancer survivors are a high-priority, underserved population for HPV vaccination. They are less likely to be vaccinated when compared to the general popu...

$2M
USD
Completed OTHER RESEARCH-RELATED
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2024 – 2025

PROJECT SUMMARY Chimeric antigen receptor (CAR) T cell therapy is a novel form of cellular immunotherapy in which the antigen specificity of T cells is redirected using synthetic r...

$2.63M
USD
Active OTHER RESEARCH-RELATED
Discerning mechanisms of semaphorin 7A-mediated tumor progression via immunoevasion
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2028

Project We Summary/Abstract have identified that semaphorin 7a (SEMA7A)—a signaling molecule that activates integrin-β1 signaling in cancer—is upregulated in postpartum breast canc...

$990.2K
USD
Completed RESEARCH CENTERS
Federated Learning Framework for Multimodal Survival Analysis in Pediatric Cancers
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2024 – 2025

Overall Summary/Abstract Childhood cancers, although rare, significantly impact thousands of children globally each year. The complexity and variability of these cancers necessitat...

$1.81M
USD
Completed NON-SBIR/STTR RPGS
SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use
NATIONAL CANCER INSTITUTE Kaiser Foundation Research Institute United States 2024 – 2024

Abstract Serologic testing for presence of SARS-CoV-2 antibodies is a critical tool for understanding the epidemiology and designing control strategies for the COVID-19 pandemic. O...

$3.03M
USD
Completed RESEARCH CENTERS
Tulane University COVID Antibody and Immunity Network (TUCAIN) Supplement
NATIONAL CANCER INSTITUTE Tulane University of Louisiana United States 2024 – 2025

ABSTRACT The SARS-CoV-2 virus, the causative agent of COVID-19, has infected a reported 13,810,247 persons globally as of July 16, 2020 with a mortality rate of 4.2%. In the State...

$3.1M
USD
Active OTHER RESEARCH-RELATED
A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2024 – 2028

PROJECT SUMMARY / ABSRACT CIBMTR (Center for International Blood and Marrow Transplant Research) represents an international network of >360 treatment centers and maintains a cl...

$7.57M
USD
Active OTHER RESEARCH-RELATED
Targeting regenerative reprogramming in colorectal cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2028

ABSTRACT Poorly defined fitness features enable a subset of cancer cells to survive therapy, ultimately giving rise to treatment-refractory tumors. The expanded use of sequencing t...

$2.93M
USD
Active OTHER RESEARCH-RELATED
Chromatin and immune regulation of tumor growth and progression
NATIONAL CANCER INSTITUTE Whitehead Institute for Biomedical Res United States 2024 – 2028

PROJECT SUMMARY Lung and pancreatic ductal adenocarcinomas are often diagnosed at very late stages of tumor progression when they are most aggressive and difficult to treat. Curren...

$1.03M
USD
Completed NON-SBIR/STTR RPGS
Targeting Oxidized PTP1B for Anticancer Drug Discovery
NATIONAL CANCER INSTITUTE Florida Atlantic University United States 2024 – 2026

PROJECT SUMMARY PTP1B, a non-receptor–type oncogenic PTP, also known as PTPN1, is involved in growth factor signaling. The PTP1B gene is frequently amplified in cancers and correla...

$593K
USD
Completed RESEARCH CENTERS
Cancer Center Administration
NATIONAL CANCER INSTITUTE Dartmouth College United States 2024 – 2024

Project Summary/Abstract: Administration Norris Cotton Cancer Center (NCCC) Administration bridges the Geisel School of Medicine at Dartmouth College (Geisel) and Dartmouth-Hitchco...

Completed RESEARCH CENTERS
Cancer Research Career Enhancement
NATIONAL CANCER INSTITUTE Dartmouth College United States 2024 – 2024

Project Summary/Abstract: Career Enhancement Norris Cotton Cancer Center (NCCC) is a central provider and resource of Career Enhancement activities for its trainees, Program Member...